Literature DB >> 7615272

Chronology of p53 protein accumulation in gastric carcinogenesis.

M E Craanen1, P Blok, W Dekker, G J Offerhaus, G N Tytgat.   

Abstract

p53 Protein accumulation in early gastric carcinoma was studied in relation to the histological type (Lauren classification) and the type of growth pattern, including the chronology of p53 protein accumulation during carcinogenesis. Forty five, paraffin embedded gastrectomy specimens from early carcinomas were examined for the presence of chronic atrophic gastritis, subtypes of intestinal metaplasia, and dysplasia. The Lauren type and the type of growth pattern were reassessed for all early carcinomas. p53 Protein accumulation was examined using the monoclonal antibody DO-7. Complete absence of p53 protein accumulation was observed in normal gastric mucosa, chronic atrophic gastritis, and intestinal metaplasia, irrespective of subtype. In gastric dysplasia (one mild, two moderate, and one severe), only severe dysplasia was p53 positive. Intestinal type (n = 20) and diffuse type early gastric carcinomas (n = 25) were p53 positive in 70% and 52% of cases, respectively. Both tumour types differed significantly in the percentage of p53 positive tumour cells per tumour (p < 0.01) and in staining intensity (p < 0.05). No significant difference in p53 protein accumulation was found between early carcinomas with different types of growth pattern. It is concluded that p53 protein accumulation--usually reflecting missense p53 gene mutation--seems to be a late event in gastric carcinogenesis. Moreover, it is suggested that missense p53 gene mutation occurs in a final pathway common to both intestinal and diffuse type of early gastric carcinoma. Finally, the types of growth pattern do not seem to differ in p53 protein accumulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615272      PMCID: PMC1382621          DOI: 10.1136/gut.36.6.848

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Overexpression and mutation of p53 in epithelial ovarian cancer.

Authors:  J R Marks; A M Davidoff; B J Kerns; P A Humphrey; J C Pence; R K Dodge; D L Clarke-Pearson; J D Iglehart; R C Bast; A Berchuck
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

3.  Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

Authors:  L Banks; G Matlashewski; L Crawford
Journal:  Eur J Biochem       Date:  1986-09-15

4.  Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications.

Authors:  K Davessar; J C Pezzullo; N Kessimian; J H Hale; H O Jauregui
Journal:  Hum Pathol       Date:  1990-03       Impact factor: 3.466

5.  Histologic types of gastric carcinoma in high- and low-risk areas.

Authors:  N Muñoz; P Correa; C Cuello; E Duque
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

6.  Precursors of gastric and esophageal cancer.

Authors:  P Correa
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

7.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

8.  Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types.

Authors:  Y Kodama; K Inokuchi; K Soejima; T Matsusaka; T Okamura
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

9.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

10.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

Authors:  J V Gannon; R Greaves; R Iggo; D P Lane
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

View more
  15 in total

1.  Evaluation of mucin expression patterns in gastric borderline (group III) lesions.

Authors:  Hideki Minematsu; Yasuharu Saito; Rie Kakinoki; Akira Andoh; Ryoji Kushima; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

2.  Ataxin-3 expression correlates with the clinicopathologic features of gastric cancer.

Authors:  Li-Xia Zeng; Yong Tang; Yun Ma
Journal:  Int J Clin Exp Med       Date:  2014-04-15

3.  Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.

Authors:  I O Baas; B P van Rees; A Musler; M E Craanen; G N Tytgat; F M van den Berg; G J Offerhaus
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

Review 4.  Hypermutability in carcinogenesis.

Authors:  B S Strauss
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

5.  Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.

Authors:  G Nardone; S Staibano; A Rocco; E Mezza; F P D'armiento; L Insabato; A Coppola; G Salvatore; A Lucariello; N Figura; G De Rosa; G Budillon
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

6.  Immunohistochemical evaluation of keratin 20 expression in intestinal metaplasia types I to III.

Authors:  M J Schwerer; K Baczako
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

7.  Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection.

Authors:  Fredrik Petersson; Kurt Borch; Lennart E Franzén
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

8.  Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression.

Authors:  J Nishikawa; S Imai; T Oda; T Kojima; K Okita; K Takada
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Genetic alterations in benign lesions: chronic gastritis and gastric ulcer.

Authors:  Ana Cristina Gobbo César; Marília de Freitas Calmon; Patrícia Maluf Cury; Alaor Caetano; Aldenis Albaneze Borim; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

10.  Absence of ras gene mutations in early gastric carcinomas.

Authors:  M E Craanen; P Blok; B Top; L Boerrigter; W Dekker; G J Offerhaus; G N Tytgat; S Rodenhuis
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.